Novavax continues on it’s commercialization journey

falleno
2022-01-01

$Novavax(NVAX)$ Longs, let’s take the proper perspective on filing of the required CMC data to the FDA, it is yet another step towards FDA approval, which considering the prior approvals by WHO, EU, India, Indonesia and Philippines and everything scientific we know about Cov-2373, emergency use and eventually BLA use will be granted to Novavax likely by the end of February. We’ve waited this long, whats another 45-60 days? Besides, many more approvals from other countries will occur during that same time.

For you naysayers that are hung up that US based CMC (Fuji-Texas) data was not included in todays filing, well that just tells you about the state of manufacturing in the USA. Just about every industry in the USA has outsourced parts or all their manufacturing to overseas partners. Where do you think most of the world’s medicines are made? For that matter, much of the clothes we wear, the electronics we use, the foods we eat and the cars we drive come from other countries that have proven that they can manufacture it better and cheaper. Nobody put a gun to your head for you to buy that, Toyota, iPhone or Air Jordan’s. Having the serum institute of India as a strategic partner is a huge asset to Novavax.

Finally, learn to check your emotions at the door when you invest. Stay with your thesis when you invest a company. Novavax continues on it’s commercialization journey and the SP will follow its success. The need for Covid vaccines will continue for many, many years, all the scientists worldwide agree on this. Glta. Cheers.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法